Capstone Investment Advisors
MNTA

Capstone Investment Advisors’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Capstone Investment Advisors’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-453,362
Closed -$23.8M – 1805
2020
Q3 		$23.8M Buy
+453,362
New +$18.8M 0.12% 147
2014
Q3 		– Sell
-15,900
Closed -$192K – 514
2014
Q2 		$192K Sell
15,900
-22,500
-59% -$266K ﹤0.01% 383
2014
Q1 		$447K Buy
+38,400
New +$650K 0.01% 331

Capstone Investment Advisors's MNTA Position: Q4 2020 in Review

Capstone Investment Advisors sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 453,362 shares — an estimated $23.8M sold.

Capstone Investment Advisors first reported a position in MNTA in Q1 2014 and held it in 3 quarters. The position peaked at $23.8M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

  • Capstone Investment Advisors reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
  • Capstone Investment Advisors sold 453,362 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $23.8M.
  • Capstone Investment Advisors first reported a position in Momenta Pharmaceuticals, Inc. in Q1 2014 and held it in 3 quarters.
  • Capstone Investment Advisors's Momenta Pharmaceuticals, Inc. position peaked at $23.8M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on Capstone Investment Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.